Stephen C. Glover's Net Worth
$28.1 Million
Who is Stephen C. Glover?
Stephen C. Glover has an estimated net worth of $28.1 Million. This is based on reported shares across multiple companies, which include ANDRX CORP /DE/, INSMED Inc, PDS Biotechnology Corp, Ambrx Biopharma Inc., ZyVersa Therapeutics, Inc., AURIGA LABORATORIES, INC., and Ambrx Biopharma, Inc..
SEC CIK
Stephen C. Glover's CIK is 0001304406
Past Insider Trading and Trends
2022 was Stephen C. Glover's most active year for acquiring shares with 11 total transactions. Stephen C. Glover's most active month to acquire stocks was the month of May. 2024 was Stephen C. Glover's most active year for disposing of shares, totalling 4 transactions. Stephen C. Glover's most active month to dispose stocks was the month of February. 2021 saw Stephen C. Glover paying a total of $49,997.00 for 14,882 shares, this is the most they've acquired in one year. In 2009 Stephen C. Glover cashed out on 569,811 shares for a total of $337,430.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANDRX CORP /DE/ No price found
SVP Brand Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,389.08% | 7K |
—
|
—
| 7.29K |
Nov 19
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INSMED Inc (INSM) Snapshot price: $71.04
President Follow-on Biologics
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.89% | 3.27K |
$1.00 | -$337,430.00 | 372.11K |
Mar 31
| |||
Form 4
| +361.06% | 288.85K |
—
|
—
| 368.85K |
May 29
| |||
Form 4
|
∞
| 80K |
$0.79 | $62,936.06 | 80K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDS Biotechnology Corp (PDSB) Snapshot price: $2.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +10.16% | 5.88K |
$8.50 | $49,997.00 | 63.79K |
Jun 15 - Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
| +196.84% | 38.4K |
$1.30 | $49,920.00 | 57.91K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ambrx Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 85K |
—
|
—
| 85K |
May 18 - Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZyVersa Therapeutics, Inc. (ZVSA) Snapshot price: $2.95
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
∞
| 627.83K |
—
|
—
| 627.83K |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||